MedTrace Logo

Functional and Physiological Responses to Lokomat Therapy (Pilot Study)

NCT00883142 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 27

Last updated 2013-06-11

No results posted yet for this study

Summary

Individuals with neurological deficiencies such as those who have spinal cord injury, stroke, traumatic brain injury, Parkinson's disease, and multiple sclerosis often lose their ability to ambulate over ground. Loss of functional mobility not only impedes everyday life, but may also affect many systems and organs in the body. The investigators are interested in obtaining a wide variety of data in order to obtain a better understanding of changes that occur as a result of receiving Lokomat therapy. The investigators will be studying body composition, cardiac, pulmonary, endocrine, metabolic, and molecular changes after a 12-week clinical therapy program.

Conditions

Sponsors & Collaborators

Principal Investigators

  • Ann M. Spungen, EdD · VA Medical Center, Bronx

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-10-31
Primary Completion
2012-08-31
Completion
2013-03-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00883142 on ClinicalTrials.gov